Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Linda Kaplan who wrote (3059)	3/26/1998 9:33:00 AM
From: Brander	Read Replies (1) of 7041

Linda, got up on the wrong side of the bed, saw your post and fired off a quick response....hehehe...sorry. My position concerning the new patent is this. I was leaning short. I did not think the patent was going to be approved because I didn't think Vasomax was unique enough. The patent office seems to think that Vasomax is special enough to deserve a patent. This has, for now, changed my point of view. Although the patent itself will not directly have any influence (or shouldn't)on the FDA decision, the fact that Vasomax appears to be unique and different from anything else could be significant in the decision. Of course, it also has to be effective and safe. Brad

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next